Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antineoplastic agent cytotoxic drug |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:CASNumber |
51-75-2
|
| gptkbp:category |
gptkb:nitrogen_mustards
antineoplastic agent vesicant |
| gptkbp:discoveredIn |
1940s
|
| gptkbp:hasMolecularFormula |
C5H11Cl2N
|
| gptkbp:mechanismOfAction |
DNA crosslinking
|
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:relatedTo |
mustard gas
|
| gptkbp:sideEffect |
nausea
vomiting bone marrow suppression |
| gptkbp:synonym |
gptkb:HN2
gptkb:mechlorethamine mustine |
| gptkbp:toxicity |
humans
|
| gptkbp:usedFor |
chemotherapy
treatment of cancer treatment of lymphoma |
| gptkbp:bfsParent |
gptkb:cyclophosphamide
gptkb:Mustard_Gas |
| gptkbp:bfsLayer |
6
|